MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway

Clin Transl Oncol. 2022 Feb;24(2):266-275. doi: 10.1007/s12094-021-02683-w. Epub 2021 Jul 27.

Abstract

Purpose: Increasing evidences suggest dysfunctions of microRNAs (miRNAs) are playing important part in tumors. Therefore, the role of miR-802 in osteosarcoma (OS) was exploited. The object was to evaluate the effect of miR-802 and verify its influence on p27 Kip1 (p27) in OS.

Methods: RT-qPCR experiment was used to detect miR-802 and p27 expression in OS tissues and cells. We explored the function of miR-802 through Transwell assays. The phosphoinositide 3-kinase (PI3K)/AKT serine/threonine kinase pathway and epithelial-mesenchymal transition (EMT) was detected by Western blot assays. Luciferase assay was used to testify the target of miR-802.

Results: MiR-802 expression was elevated in OS, which was related to poor clinical outcome in OS patients. MiR-802 overexpression promoted OS migration, invasion and EMT. Further, p27 is a direct target of miR-802. P27 elevation counteracted the promotion effect of OS on EMT, migration and invasion induced by miR-802. In addition, miR-802 overexpression inactivated PI3K/AKT pathway via targeting p27 in OS.

Conclusion: MiR-802 promoted the progress of EMT, migration and invasion in OS via targeting p27. This newly identified miR-802/p27/PI3K/AKT axis may represent potential targets for OS.

Keywords: Invasion; MiR-802; Migration; Osteosarcoma; p27.

MeSH terms

  • Adolescent
  • Bone Neoplasms / etiology*
  • Bone Neoplasms / pathology
  • Cyclin-Dependent Kinase Inhibitor p27 / physiology*
  • Disease Progression
  • Female
  • Humans
  • Male
  • MicroRNAs / physiology*
  • Osteosarcoma / etiology*
  • Osteosarcoma / pathology
  • Phosphatidylinositol 3-Kinases / physiology*
  • Proto-Oncogene Proteins c-akt / physiology*
  • Young Adult

Substances

  • CDKN1B protein, human
  • MIRN802 microRNA, human
  • MicroRNAs
  • Cyclin-Dependent Kinase Inhibitor p27
  • Proto-Oncogene Proteins c-akt